PortfoliosLab logoPortfoliosLab logo
VRTX vs. VLO
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

VRTX vs. VLO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vertex Pharmaceuticals Incorporated (VRTX) and Valero Energy Corporation (VLO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

VRTX vs. VLO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VRTX
Vertex Pharmaceuticals Incorporated
-1.50%12.58%-1.03%40.90%31.50%-7.08%7.94%32.13%10.58%103.42%
VLO
Valero Energy Corporation
52.71%36.97%-2.96%5.86%74.95%40.25%-35.69%30.27%-15.73%38.66%

Fundamentals

Market Cap

VRTX:

$114.36B

VLO:

$74.87B

EPS

VRTX:

$15.35

VLO:

$7.74

PE Ratio

VRTX:

29.09

VLO:

31.93

PEG Ratio

VRTX:

2.42

VLO:

0.12

PS Ratio

VRTX:

9.58

VLO:

0.61

PB Ratio

VRTX:

6.13

VLO:

2.81

Total Revenue (TTM)

VRTX:

$12.00B

VLO:

$124.05B

Gross Profit (TTM)

VRTX:

$10.35B

VLO:

$6.75B

EBITDA (TTM)

VRTX:

$4.74B

VLO:

$6.49B

Returns By Period

In the year-to-date period, VRTX achieves a -1.50% return, which is significantly lower than VLO's 52.71% return. Both investments have delivered pretty close results over the past 10 years, with VRTX having a 18.89% annualized return and VLO not far ahead at 19.18%.


VRTX

1D
0.76%
1M
-10.12%
YTD
-1.50%
6M
14.02%
1Y
-7.90%
3Y*
12.33%
5Y*
15.95%
10Y*
18.89%

VLO

1D
-1.27%
1M
20.74%
YTD
52.71%
6M
46.93%
1Y
92.58%
3Y*
24.69%
5Y*
31.29%
10Y*
19.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VRTX vs. VLO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRTX
VRTX Risk / Return Rank: 3131
Overall Rank
VRTX Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
VRTX Sortino Ratio Rank: 2929
Sortino Ratio Rank
VRTX Omega Ratio Rank: 2929
Omega Ratio Rank
VRTX Calmar Ratio Rank: 3232
Calmar Ratio Rank
VRTX Martin Ratio Rank: 3131
Martin Ratio Rank

VLO
VLO Risk / Return Rank: 9292
Overall Rank
VLO Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
VLO Sortino Ratio Rank: 9090
Sortino Ratio Rank
VLO Omega Ratio Rank: 9191
Omega Ratio Rank
VLO Calmar Ratio Rank: 9292
Calmar Ratio Rank
VLO Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRTX vs. VLO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and Valero Energy Corporation (VLO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VRTXVLODifference

Sharpe ratio

Return per unit of total volatility

-0.22

2.40

-2.62

Sortino ratio

Return per unit of downside risk

-0.05

2.86

-2.91

Omega ratio

Gain probability vs. loss probability

0.99

1.41

-0.42

Calmar ratio

Return relative to maximum drawdown

-0.33

4.30

-4.64

Martin ratio

Return relative to average drawdown

-0.65

12.77

-13.42

VRTX vs. VLO - Sharpe Ratio Comparison

The current VRTX Sharpe Ratio is -0.22, which is lower than the VLO Sharpe Ratio of 2.40. The chart below compares the historical Sharpe Ratios of VRTX and VLO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


VRTXVLODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.22

2.40

-2.62

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.56

0.86

-0.30

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.57

0.48

+0.09

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.28

-0.02

Correlation

The correlation between VRTX and VLO is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

VRTX vs. VLO - Dividend Comparison

VRTX has not paid dividends to shareholders, while VLO's dividend yield for the trailing twelve months is around 1.86%.


TTM20252024202320222021202020192018201720162015
VRTX
Vertex Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VLO
Valero Energy Corporation
1.86%2.78%3.49%3.14%3.09%5.22%6.93%3.84%4.27%2.34%3.51%2.40%

Drawdowns

VRTX vs. VLO - Drawdown Comparison

The maximum VRTX drawdown since its inception was -91.77%, roughly equal to the maximum VLO drawdown of -87.50%. Use the drawdown chart below to compare losses from any high point for VRTX and VLO.


Loading graphics...

Drawdown Indicators


VRTXVLODifference

Max Drawdown

Largest peak-to-trough decline

-91.77%

-87.50%

-4.27%

Max Drawdown (1Y)

Largest decline over 1 year

-28.06%

-21.72%

-6.34%

Max Drawdown (5Y)

Largest decline over 5 years

-29.07%

-41.22%

+12.15%

Max Drawdown (10Y)

Largest decline over 10 years

-41.60%

-71.88%

+30.28%

Current Drawdown

Current decline from peak

-13.59%

-2.85%

-10.74%

Average Drawdown

Average peak-to-trough decline

-37.81%

-34.39%

-3.42%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.33%

7.32%

+7.01%

Volatility

VRTX vs. VLO - Volatility Comparison

Vertex Pharmaceuticals Incorporated (VRTX) and Valero Energy Corporation (VLO) have volatilities of 11.93% and 11.92%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


VRTXVLODifference

Volatility (1M)

Calculated over the trailing 1-month period

11.93%

11.92%

+0.01%

Volatility (6M)

Calculated over the trailing 6-month period

21.67%

25.37%

-3.70%

Volatility (1Y)

Calculated over the trailing 1-year period

35.83%

38.84%

-3.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.77%

36.71%

-7.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.24%

40.18%

-6.94%

Financials

VRTX vs. VLO - Financials Comparison

This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and Valero Energy Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
3.19B
31.73B
(VRTX) Total Revenue
(VLO) Total Revenue
Values in USD except per share items

VRTX vs. VLO - Profitability Comparison

The chart below illustrates the profitability comparison between Vertex Pharmaceuticals Incorporated and Valero Energy Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
85.4%
10.3%
Portfolio components
VRTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.72B and revenue of 3.19B. Therefore, the gross margin over that period was 85.4%.

VLO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Valero Energy Corporation reported a gross profit of 3.26B and revenue of 31.73B. Therefore, the gross margin over that period was 10.3%.

VRTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported an operating income of 1.26B and revenue of 3.19B, resulting in an operating margin of 39.6%.

VLO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Valero Energy Corporation reported an operating income of 1.58B and revenue of 31.73B, resulting in an operating margin of 5.0%.

VRTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported a net income of 1.19B and revenue of 3.19B, resulting in a net margin of 37.3%.

VLO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Valero Energy Corporation reported a net income of 1.17B and revenue of 31.73B, resulting in a net margin of 3.7%.